Signal Transducer and Activator of Transcription-5 Activation and Breast Cancer Prognosis
Authors:
- 1 June 2004
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (11) , 2053-2060
Abstract
Purpose Transcription factor signal transducer and activator of transcription-5 (Stat5) promotes breast epithelial cell differentiation. We retrospectively analyzed whether levels of active Stat5 in breast cancer were linked to clinical outcome. Materials and Methods Immunohistochemistry was used to detect active, tyrosine-phosphorylated Stat5 in paraffin-embedded breast cancer specimens from three archival tissue microarray materials A, B, and C. Material A included 19 healthy human breast tissues and a progression series of primary lymph node-negative, primary lymph node-positive, and metastatic breast cancer (n = 400). Materials B (n = 785) and C (n = 570) represented two independent arrays of unselected primary breast cancer specimens with clinical follow-up data. Results Material A demonstrated that Stat5 activation, but not Stat5 protein expression, was gradually lost during cancer progression, with detectable activation in 100% of healthy breast specimens compared with less than 20% of node-positive breast cancers and metastases. Stat5 activation in tumors of material B was associated with favorable prognosis. This observation was confirmed and extended in material C to include both breast cancer-specific survival and disease-free survival. Stat5 activation remained an independent prognostic marker after adjusting for patient age, tumor size, histological grade, estrogen receptor, progesterone receptor, and Her2/neu status by Cox multivariate analysis (hazard ratio, 2.0; P = .029). Stat5 activation was a particularly favorable marker in the lymph node-negative breast cancer subpopulation (hazard ratio, 7.5; P = .003). Conclusion In our study, active Stat5 distinguishes breast cancer patients with favorable prognosis, and may be a useful marker for selection of more individualized treatment, especially in localized disease. These findings require confirmation in a large prospective study.Keywords
This publication has 22 references indexed in Scilit:
- KIT (CD117)-Positive Breast Cancers Are Infrequent and Lack KIT Gene MutationsClinical Cancer Research, 2004
- Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancersInternational Journal of Cancer, 2003
- The role of stat5 in estrogen receptor-positive breast cancerBreast Cancer, 2002
- Loss of Stat5a delays mammary cancer progression in a mouse modelOncogene, 2002
- Basal Activation of Transcription Factor Signal Transducer and Activator of Transcription (Stat5) in Nonpregnant Mouse and Human Breast EpitheliumMolecular Endocrinology, 2002
- Role of Tyrosine Kinase Jak2 in Prolactin-induced Differentiation and Growth of Mammary Epithelial CellsJournal of Biological Chemistry, 2002
- Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epitheliumJournal of Cell Biology, 2001
- Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancerProceedings of the National Academy of Sciences, 2001
- Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine ResponsesCell, 1998
- Stat5a is mandatory for adult mammary gland development and lactogenesis.Genes & Development, 1997